Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.
Publication
, Journal Article
Czito, BG; Willett, CG
Published in: Semin Radiat Oncol
July 2011
The management of rectal cancer has undergone significant evolution with advances in surgery, radiation therapy, and chemotherapy. These advances have translated into improved rates of local control, survival, and quality of life. More recently, the integration of newer chemotherapeutic and targeted agents in patients with advanced colorectal cancer have led to further improvements in disease-free and overall survival. These agents are now being studied with radiation therapy in the neoadjuvant therapy of rectal cancer.
Duke Scholars
Published In
Semin Radiat Oncol
DOI
EISSN
1532-9461
Publication Date
July 2011
Volume
21
Issue
3
Start / End Page
203 / 211
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Survival Rate
- Rectal Neoplasms
- Radiotherapy, Adjuvant
- Quality of Life
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Neoadjuvant Therapy
- Humans
- Fluorouracil
Citation
APA
Chicago
ICMJE
MLA
NLM
Czito, B. G., & Willett, C. G. (2011). Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. Semin Radiat Oncol, 21(3), 203–211. https://doi.org/10.1016/j.semradonc.2011.02.006
Czito, Brian G., and Christopher G. Willett. “Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.” Semin Radiat Oncol 21, no. 3 (July 2011): 203–11. https://doi.org/10.1016/j.semradonc.2011.02.006.
Czito BG, Willett CG. Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. Semin Radiat Oncol. 2011 Jul;21(3):203–11.
Czito, Brian G., and Christopher G. Willett. “Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.” Semin Radiat Oncol, vol. 21, no. 3, July 2011, pp. 203–11. Pubmed, doi:10.1016/j.semradonc.2011.02.006.
Czito BG, Willett CG. Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. Semin Radiat Oncol. 2011 Jul;21(3):203–211.
Published In
Semin Radiat Oncol
DOI
EISSN
1532-9461
Publication Date
July 2011
Volume
21
Issue
3
Start / End Page
203 / 211
Location
United States
Related Subject Headings
- Vascular Endothelial Growth Factor A
- Survival Rate
- Rectal Neoplasms
- Radiotherapy, Adjuvant
- Quality of Life
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Neoadjuvant Therapy
- Humans
- Fluorouracil